BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 35900229)

  • 1. Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals.
    Saponaro C; Sabatini S; Gaggini M; Carli F; Rosso C; Positano V; Armandi A; Caviglia GP; Faletti R; Bugianesi E; Gastaldelli A
    Liver Int; 2022 Nov; 42(11):2418-2427. PubMed ID: 35900229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
    Rosso C; Kazankov K; Younes R; Esmaili S; Marietti M; Sacco M; Carli F; Gaggini M; Salomone F; Møller HJ; Abate ML; Vilstrup H; Gastaldelli A; George J; Grønbæk H; Bugianesi E
    J Hepatol; 2019 Nov; 71(5):1012-1021. PubMed ID: 31301321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Adipose Tissue Fibrogenesis, Not Impaired Expandability, Is Associated With Nonalcoholic Fatty Liver Disease.
    Beals JW; Smith GI; Shankaran M; Fuchs A; Schweitzer GG; Yoshino J; Field T; Matthews M; Nyangau E; Morozov D; Mittendorfer B; Hellerstein MK; Klein S
    Hepatology; 2021 Sep; 74(3):1287-1299. PubMed ID: 33743554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance in lean and overweight non-diabetic Caucasian adults: Study of its relationship with liver triglyceride content, waist circumference and BMI.
    Gonzalez-Cantero J; Martin-Rodriguez JL; Gonzalez-Cantero A; Arrebola JP; Gonzalez-Calvin JL
    PLoS One; 2018; 13(2):e0192663. PubMed ID: 29425212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent pathways of liver fat accumulation, oxidation, and secretion in lipodystrophy versus obesity-associated NAFLD.
    Klein RJ; Viana Rodriguez GM; Rotman Y; Brown RJ
    Liver Int; 2023 Dec; 43(12):2692-2700. PubMed ID: 37622286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease.
    Lomonaco R; Ortiz-Lopez C; Orsak B; Webb A; Hardies J; Darland C; Finch J; Gastaldelli A; Harrison S; Tio F; Cusi K
    Hepatology; 2012 May; 55(5):1389-97. PubMed ID: 22183689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.
    Markova M; Pivovarova O; Hornemann S; Sucher S; Frahnow T; Wegner K; Machann J; Petzke KJ; Hierholzer J; Lichtinghagen R; Herder C; Carstensen-Kirberg M; Roden M; Rudovich N; Klaus S; Thomann R; Schneeweiss R; Rohn S; Pfeiffer AF
    Gastroenterology; 2017 Feb; 152(3):571-585.e8. PubMed ID: 27765690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH.
    Gastaldelli A; Sabatini S; Carli F; Gaggini M; Bril F; Belfort-DeAguiar R; Positano V; Barb D; Kadiyala S; Harrison S; Cusi K
    Liver Int; 2021 Nov; 41(11):2659-2670. PubMed ID: 34219361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin-leptin ratio for the early detection of lean non-alcoholic fatty liver disease independent of insulin resistance.
    Lu CW; Yang KC; Chi YC; Wu TY; Chiang CH; Chang HH; Huang KC; Yang WS
    Ann Med; 2023 Dec; 55(1):634-642. PubMed ID: 36790383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD.
    Kalavalapalli S; Leiva EG; Lomonaco R; Chi X; Shrestha S; Dillard R; Budd J; Romero JP; Li C; Bril F; Samraj G; Pennington J; Townsend P; Orlando F; Shetty S; Mansour L; Silva-Sombra LR; Bedossa P; Malaty J; Barb D; Gurka MJ; Cusi K
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1192-1201. PubMed ID: 36378995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral adipose tissue tracks more closely with metabolic dysfunction than intrahepatic triglyceride in lean Asians without diabetes.
    Ding C; Chan Z; Chooi YC; Choo J; Sadananthan SA; Michael N; Velan SS; Leow MKS; Magkos F
    J Appl Physiol (1985); 2018 Sep; 125(3):909-915. PubMed ID: 29745794
    [TBL] [Abstract][Full Text] [Related]  

  • 13.  Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFLD).
    Choudhary NS; Duseja A; Kalra N; Das A; Dhiman RK; Chawla YK
    Ann Hepatol; 2012; 11(4):478-86. PubMed ID: 22700629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
    Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
    Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypical heterogeneity linked to adipose tissue dysfunction in patients with Type 2 diabetes.
    Barchetta I; Angelico F; Del Ben M; Di Martino M; Cimini FA; Bertoccini L; Polimeni L; Catalano C; Fraioli A; Del Vescovo R; Morini S; Baroni MG; Cavallo MG
    Clin Sci (Lond); 2016 Oct; 130(19):1753-62. PubMed ID: 27458255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations Among Adipose Tissue Immunology, Inflammation, Exosomes and Insulin Sensitivity in People With Obesity and Nonalcoholic Fatty Liver Disease.
    Fuchs A; Samovski D; Smith GI; Cifarelli V; Farabi SS; Yoshino J; Pietka T; Chang SW; Ghosh S; Myckatyn TM; Klein S
    Gastroenterology; 2021 Sep; 161(3):968-981.e12. PubMed ID: 34004161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease.
    Bril F; Barb D; Portillo-Sanchez P; Biernacki D; Lomonaco R; Suman A; Weber MH; Budd JT; Lupi ME; Cusi K
    Hepatology; 2017 Apr; 65(4):1132-1144. PubMed ID: 27981615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents.
    Deivanayagam S; Mohammed BS; Vitola BE; Naguib GH; Keshen TH; Kirk EP; Klein S
    Am J Clin Nutr; 2008 Aug; 88(2):257-62. PubMed ID: 18689359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.
    Milić S; Lulić D; Štimac D
    World J Gastroenterol; 2014 Jul; 20(28):9330-7. PubMed ID: 25071327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in the association between adipose insulin resistance and non-alcoholic fatty liver disease in Chinese adults.
    Wei Y; Liu J; Wang G; Wang Y
    Biol Sex Differ; 2023 Oct; 14(1):69. PubMed ID: 37814297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.